Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 2Lymphoid 2Head & Neck 2Genitourinary 2Endocrine 2Dermatologic 2Thoracic 1Other hematologic neoplasm 1NET 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Sarcoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Breast Neoplasms 2Thyroid Cancer, Papillary 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Neuroendocrine Tumors 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3pembrolizumab 2Radiosurgery 2Paclitaxel 2Nivolumab 2Ipilimumab 2FAPI-46 2tipifarnib 1sodium thiosulfate 1sargramostim 1regorafenib 1montelukast 1entrectinib 1entinostat 1cediranib 1cc-486 1carboxyamido-triazole 1alectinib 1aflibercept 1Trastuzumab 1Thiotepa 1Tablets 1Specimen Handling 1Sirolimus 1Sevoflurane 1Ritonavir 1Restraint, Physical 1Radiotherapy 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × entrectinib × Gynecologic × Clear all
NCT02568267 2026-05-27

STARTRK-2

Hoffmann-La Roche

Phase 2 Active not recruiting
534 enrolled 1 FDA
BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidNETSarcomaThoracic

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡